NCT05355935View on ClinicalTrials.gov

A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 27, 2022

Primary Completion Date

October 7, 2022

Study Completion Date

October 7, 2022

Conditions

Healthy Volunteer

Interventions

DRUG

Brensocatib

Oral tablet.

DRUG

Moxifloxacin

Oral tablet.

DRUG

Placebo

Oral tablet.

Trial Locations (1)

53704

USA001, Madison

All Listed Sponsors

lead

Insmed Incorporated

INDUSTRY